UBS Group Increases Philip Morris International (NYSE:PM) Price Target to $120.00

Philip Morris International (NYSE:PM) had its price objective raised by analysts at UBS Group from $105.00 to $120.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage presently has a “sell” rating on the stock. UBS Group’s target price points to a potential downside of 17.28% from the stock’s previous close.

A number of other research analysts have also commented on PM. Barclays cut their target price on Philip Morris International from $155.00 to $145.00 and set an “overweight” rating for the company in a research note on Wednesday, January 8th. JPMorgan Chase & Co. boosted their target price on shares of Philip Morris International from $125.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday, October 23rd. Stifel Nicolaus reiterated a “buy” rating and set a $145.00 price objective (up from $138.00) on shares of Philip Morris International in a research report on Wednesday, October 23rd. Finally, Morgan Stanley initiated coverage on shares of Philip Morris International in a research note on Thursday, January 16th. They issued an “overweight” rating and a $140.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $134.35.

Philip Morris International Trading Down 0.2 %

NYSE:PM traded down $0.25 on Friday, reaching $145.07. The stock had a trading volume of 1,957,499 shares, compared to its average volume of 5,309,600. The company has a 50-day moving average of $125.44 and a 200 day moving average of $123.61. The stock has a market cap of $225.56 billion, a P/E ratio of 23.02, a price-to-earnings-growth ratio of 2.30 and a beta of 0.55. Philip Morris International has a 12-month low of $87.82 and a 12-month high of $146.78.

Philip Morris International (NYSE:PM) last released its quarterly earnings results on Thursday, February 6th. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.49 by $0.06. Philip Morris International had a net margin of 10.35% and a negative return on equity of 117.94%. On average, equities analysts predict that Philip Morris International will post 6.5 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of PM. State Street Corp raised its position in Philip Morris International by 0.4% during the 3rd quarter. State Street Corp now owns 54,711,621 shares of the company’s stock worth $6,715,237,000 after buying an additional 224,840 shares during the last quarter. Geode Capital Management LLC boosted its stake in Philip Morris International by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 32,101,324 shares of the company’s stock worth $3,886,818,000 after buying an additional 621,034 shares during the last quarter. FMR LLC grew its stake in shares of Philip Morris International by 40.9% during the 3rd quarter. FMR LLC now owns 23,168,446 shares of the company’s stock valued at $2,812,649,000 after buying an additional 6,721,094 shares during the period. Bank of New York Mellon Corp lifted its stake in shares of Philip Morris International by 21.0% in the 4th quarter. Bank of New York Mellon Corp now owns 16,070,482 shares of the company’s stock valued at $1,934,083,000 after purchasing an additional 2,785,987 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in Philip Morris International by 1.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 13,422,920 shares of the company’s stock worth $1,615,449,000 after buying an additional 190,201 shares during the period. Hedge funds and other institutional investors own 78.63% of the company’s stock.

About Philip Morris International

Philip Morris International Inc operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products primarily under the IQOS and ZYN brands; and consumer accessories, such as lighters and matches.